Related Experiment Videos
Underlying disease as a predictor for rejection after liver transplantation
G A Berlakovich1, S Rockenschaub, S Taucher
1Department of Transplant Surgery, University of Vienna, Austria.
Archives of Surgery (Chicago, Ill. : 1960)
|March 4, 1998
Summary
Liver transplant patients often receive too much immunosuppression, leading to infections. Underlying disease significantly impacts acute rejection risk, guiding personalized immunosuppressive therapy to improve patient outcomes.
Area of Science:
- Transplantation immunology
- Clinical outcomes research
Background:
- Overimmunosuppression is a significant concern post-liver transplantation, contributing to higher infection-related mortality than rejection.
- Individualized immunosuppression strategies are needed to balance efficacy and safety.
Purpose of the Study:
- To investigate the influence of underlying diseases on the incidence and severity of acute rejection after liver transplantation.
- To determine if underlying disease is a significant predictor for tailoring immunosuppressive therapy.
Main Methods:
- Analysis of a consecutive series of 252 liver transplant recipients from 1988 to 1995.
- Univariate and multivariate analyses were performed to assess the impact of underlying diseases (posthepatitic cirrhosis, alcoholic cirrhosis, cholestatic disease, hepatoma) on acute rejection and the need for rescue therapy.
Main Results:
- Significant differences in acute rejection rates were observed between underlying disease groups, with exceptions for alcoholic and posthepatitic cirrhosis.
- Patients with cholestatic disease required significantly more rescue therapy for acute rejection.
- Hepatoma patients showed a complex pattern of rejection, suggesting immunological variability.
- Multivariate analysis confirmed underlying disease as an independent prognostic factor for acute rejection and rescue therapy requirements.
Conclusions:
- The original disease in liver transplant recipients is a critical factor in determining appropriate immunosuppressive therapy.
- Tailoring immunosuppression based on underlying pathology can potentially reduce overimmunosuppression and improve patient survival.